Median ( @ % confidence interval ) time to beginning of symptom relief at the primary attack location was @ minutes ( @-@ ) in rhC@INH-treated patients vs @ minutes ( @ , not estimable ) in placebo-treated patients ( P = @ ) based on the TEQ and @ minutes ( @-@ ) vs @ minutes ( @-@ , P = @ ) based on a VAS decrease of at least @ mm .